Actively Recruiting
Investigating Effects of Teduglutide on Intestinal Organoids from Children with Short Bowel Syndrome
Led by Meyer Children's Hospital IRCCS · Updated on 2026-02-10
50
Participants Needed
1
Research Sites
30 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying pediatric patients with short bowel syndrome, a rare condition where significant intestinal removal causes problems with nutrient absorption and reliance on parenteral nutrition. This trial aims to understand why children respond differently to teduglutide, a drug that helps the intestine adapt and absorb nutrients better. The study uses human intestinal organoids, which are lab-grown mini-intestines from patient tissue, to explore biological reasons behind varied treatment responses. The study compares organoids treated with teduglutide to untreated ones to assess changes in intestinal structure, cell growth, gene activity, and nutrient absorption. Organoids come from intestinal tissue collected during routine surgeries and are grown and treated in the lab. No experimental treatment is given directly to the children participating the focus is on lab testing of their tissue samples. Participants provide tissue samples during standard surgical procedures, and their organoids are studied in vitro for up to seven days with and without teduglutide exposure. Researchers measure organoid size, shape, lumen size, architecture, and integrity to evaluate the drugs effects. This work aims to improve understanding of teduglutides impact and support more personalized treatments for children with short bowel syndrome in the future.
CONDITIONS
Brief Title
TED_ORG: Study on Short Bowel Syndrome
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here